Phenotypic diversity drives paracrine drug tolerance

Considerable clinical successes have been achieved in cancer treatment since the introduction of targeted therapies. However, almost inevitably tumors develop therapy resistance, which limits durable clinical responses. Tumors are often heterogeneous, and as a result, therapy‐resistant cells are present even before the start of treatment. Resistance is commonly mediated via genetic changes. However, in this issue of EMBO Molecular Medicine, Smith et al (2017) report that phenotypic heterogeneity can contribute to resistance as well.

Location
Deutsche Nationalbibliothek Frankfurt am Main
Extent
Online-Ressource
Language
Englisch

Bibliographic citation
Phenotypic diversity drives paracrine drug tolerance ; volume:9 ; number:8 ; year:2017 ; pages:987-989 ; extent:3
EMBO molecular medicine / European Molecular Biology Organization ; 9, Heft 8 (2017), 987-989 (gesamt 3)

Creator
Kuilman, Thomas
Peeper, Daniel S.

DOI
10.15252/emmm.201707956
URN
urn:nbn:de:101:1-2022100108183289773045
Rights
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
Last update
15.08.2026, 7:34 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Associated

  • Kuilman, Thomas
  • Peeper, Daniel S.

Other Objects (12)